Home » Authors » James Etheridge

Articles by James Etheridge

NicOx Grants AstraZeneca Exclusive License For Japan

Oct. 1, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

With New Premises, Tropos Launches €15M Funding Round

Sep. 11, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...